Daniel B Drachman


1960 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Daniel B Drachman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Cholinergic Receptors Medicine & Life Sciences
Myasthenia Gravis Medicine & Life Sciences
Neuromuscular Junction Medicine & Life Sciences
Autoimmune Experimental Myasthenia Gravis Medicine & Life Sciences
Muscles Medicine & Life Sciences
Botulinum Toxins Medicine & Life Sciences
Antibodies Medicine & Life Sciences
Acetylcholine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1960 2019

Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy

Mohassel, P., Landon-Cardinal, O., Foley, A. R., Donkervoort, S., Pak, K. S., Wahl, C., Shebert, R. T., Harper, A., Fequiere, P., Meriggioli, M., Toro, C., Drachman, D. B., Allenbach, Y., Benveniste, O., Béhin, A., Eymard, B., Laforet, P., Stojkovic, T., Mammen, A. L. & Bönnemann, C. G., Jan 1 2019, In : Neurology: Neuroimmunology and NeuroInflammation. 6, 1, e523.

Research output: Contribution to journalArticle

Open Access
Limb-Girdle Muscular Dystrophies
Muscular Diseases
Creatine Kinase
Genetic Testing

Comment: Methotrexate for patients with generalized myasthenia gravis

Drachman, D. B., Jul 5 2016, In : Neurology. 87, 1, p. 63 1 p.

Research output: Contribution to journalComment/debate

Myasthenia Gravis

Myasthenia Gravis

Drachman, D. B., Oct 1 2016, In : Seminars in Neurology. 36, 5, p. 419-424 6 p.

Research output: Contribution to journalArticle

Myasthenia Gravis
Cholinergic Receptors
Pyridostigmine Bromide

Treatment for refractorymyasthenia gravis- New lymphs for old

Drachman, D. B., Jun 1 2016, In : JAMA Neurology. 73, 6, p. 624-626 3 p.

Research output: Contribution to journalReview article


A genome-wide association study of myasthenia gravis

Renton, A. E., Pliner, H. A., Provenzano, C., Evoli, A., Ricciardi, R., Nalls, M. A., Marangi, G., Abramzon, Y., Arepalli, S., Chong, S., Hernandez, D. G., Johnson, J. O., Bartoccioni, E., Scuderi, F., Maestri, M., Gibbs, J. R., Errichiello, E., Chiò, A., Restagno, G., Sabatelli, M. & 35 others, Macek, M., Scholz, S. W., Corse, A. M., Chaudhry, V., Benatar, M., Barohn, R. J., McVey, A., Pasnoor, M., Dimachkie, M. M., Rowin, J., Kissel, J., Freimer, M., Kaminski, H. J., Sanders, D. B., Lipscomb, B., Massey, J. M., Chopra, M., Howard, J. F., Koopman, W. J., Nicolle, M. W., Pascuzzi, R. M., Pestronk, A., Wulf, C., Florence, J., Blackmore, D., Soloway, A., Siddiqi, Z., Muppidi, S., Wolfe, G., Richman, D., Mezei, M. M., Jiwa, T., Oger, J., Drachman, D. B. & Traynor, B. J., Apr 1 2015, In : JAMA Neurology. 72, 4, p. 396-404 9 p.

Research output: Contribution to journalArticle

Genome-Wide Association Study
Myasthenia Gravis
Odds Ratio
Major Histocompatibility Complex
Autoimmune Diseases